Pathway and Target Identification for Alzheimer's Disease Related Dementias (ADRDs) (U01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The purpose of the FOA is to support the large scale molecular platform analysis of brain tissue, human biofluid or human induced pluripotent stem cell resources for the identification of targets and pathways associated with Alzheimer's Disease Related Dementias (ADRDs) pathophysiology.


  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • Application Due Date(s): April 16, 2018‚Äč

PAR-18-661 Expiration Date April 17, 2018




Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science

External Deadline

April 16, 2018